Know Cancer

or
forgot password

Personalised Program for Women Treated for Hodgkin Disease : Risk Evaluation of Breast Cancer and Intensive Screening Program for Women at High Risk of Breast Cancer. PROPER/IPC 2010-001


N/A
18 Years
N/A
Open (Enrolling)
Female
Hodgkin Disease, Breast Cancer

Thank you

Trial Information

Personalised Program for Women Treated for Hodgkin Disease : Risk Evaluation of Breast Cancer and Intensive Screening Program for Women at High Risk of Breast Cancer. PROPER/IPC 2010-001


Inclusion Criteria:



- women > 18 years

- treated for Hodgkin disease

- signed informed consent

- high risk of breast cancer

Exclusion Criteria:

- patients unable to have a regular follow-up

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

efficacy of the screening

Outcome Description:

The efficacy of the screening will be evaluated by the rate of early stage breast cancer detected. The rate of in situ, < 10 mm(T1b), and N0 will be estimated.

Outcome Time Frame:

15 years

Safety Issue:

No

Principal Investigator

François EISINGER, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Institut Paoli-Calmettes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

PROPER/IPC 2010-001

NCT ID:

NCT01188915

Start Date:

July 2010

Completion Date:

Related Keywords:

  • Hodgkin Disease
  • Breast Cancer
  • Hodgkin disease
  • Breast cancer
  • Breast Neoplasms
  • Hodgkin Disease

Name

Location